Mark Bodmer and Jonathan Lewis of UCB pharma talk us though the partnering model at UCB, and how partnering can drive innovation. The world is changing and it’s no different for the ...
UCB Pharma has announced that Exemed Pharmaceuticals, a fast-growing Indian manufacturing company, will acquire UCB’S Indian production facility in Vapi. The deal includes a multi-year supply ...
3mon
GlobalData on MSNUCB drops Parkinson’s treatment after ORCHESTRA trial failed all endpointsBelgian pharmaceutical company UCB is dropping its development of minzasolmin in patients with Parkinson's' disease after the ...
China's commitment to foster innovation and advance high-standard opening-up has provided global pharmaceutical companies ...
UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...
The Grove AI Advisory Board brings together distinguished experts in global pharmaceutical strategy, AI innovation, and regulatory compliance. Advisory members will collaborate directly with Grove ...
UCB, a global biopharmaceutical company, today announced it will present 8 scientific abstracts, including 3 late-breaker oral presentations, highlighting key data from its innovative ...
Pharmaceutical companies are spending large sums of money on R&D in an effort to develop a new treatment that will either improve disease management or slow its progression. New technologies like ...
Comprised of prominent leaders from pharmaceutical and technology sectors, the advisory board will strategically guide Grove AI’s growth and expansion, driving its state-of-the-art technology ...
Innovation, meaning being able to bring to the market differentiated products, is the key to sustained success in the pharmaceutical industry, Tellier said. More importantly, UCB has been trying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results